(10E,12Z)-Octadeca-10,12-dienoic acid - HY-116538
89.14 mM * 400 μL in Ethanol
Nur noch %1 verfügbar
Catalog #
HY-116538
Ab
191,00 €
(10E,12Z)-Octadeca-10,12-dienoic acid (trans-10,cis-12 CLA2) is an orally active PPARα activator and inhibits adipocyte differentiation. (10E,12Z)-Octadeca-10,12-dienoic acid and its downstream metabolites have various antioxidant and antitumor activities. (10E,12Z)-Octadeca-10,12-dienoic acid can induce proinflammatory cytokines and chemokines, which would lead to decreased adipogenesis and insulin resistance in adipose tissue. (10E,12Z)-Octadeca-10,12-dienoic acid can affect many aspects of milk fat synthesis. (10E,12Z)-Octadeca-10,12-dienoic acid reduces expression of lipogenic enzymes and inhibits the desaturation of fatty acids. (10E,12Z)-Octadeca-10,12-dienoic acid can reduce lipoprotein lipase (LPL) activity in cultured 3T3-L1 adipocytes and enhance triacylglycerol release from these cells. (10E,12Z)-Octadeca-10,12-dienoic acid decreases the expression of hepatic stearoyl-CoA desatyrase mRNA in mice. (10E,12Z)-Octadeca-10,12-dienoic acid is associated with changes in mucosal NF-κB and Cyclin D1 protein levels in mice[1][2][3][4][5][6].
Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-116538/10E-12Z-Octadeca-10-12-dienoic-acid-DataSheet-MedChemExpress.pdf |
---|---|
Shipping | Blue Ice |
Application | Metabolism-sugar/lipid metabolism |
Alternative Names | trans-10,cis-12 CLA2 |
CAS | 2420-56-6 |
Storage | Solution, -20°C, 2 years |
MWT | 280.45 |
Solubility | DMSO : ≥ 50 mg/mL |
Clinical Information | No Development Reported |
Target | Endogenous Metabolite;Lipase;NF-κB;PPAR;Stearoyl-CoA Desaturase (SCD) |
Application: | Metabolism-sugar/lipid metabolism |
---|